Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)
| קרן | National Cancer Institute/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 27/09/2019 |
| פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine |
| תיאור | This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care.
Funding: $300,000 per year Duration: 3 years
Research Authority due date: 10 days prior to submission LOI (encouraged) due dates: 7.2.19, 28.4.19, 27.8.19 Full proposal due dates: 7.3.19, 28.5.19. 27.9.19
|
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 08/01/2019 |
